Evidence map›Paper›PMID 30267631›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Endoscopic Submucosal Dissection Decreases Additional Colorectal Resection for T1 Colorectal Cancer.

Yuichi Tomiki, Masaya Kawai, Shingo Kawano, Shun Ishiyama, Kiichi Sugimoto, Makoto Takahashi, Yutaka Kojima, Takashi Murakami, Hideaki Ritsuno, Tomoyoshi Shibuya and 2 more

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuichi TomikiDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Masaya KawaiDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Shingo KawanoDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Shun IshiyamaDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Kiichi SugimotoDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Makoto TakahashiDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Yutaka KojimaDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Takashi MurakamiDepartment of Gastroenterology, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Hideaki RitsunoDepartment of Gastroenterology, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Tomoyoshi ShibuyaDepartment of Gastroenterology, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Naoto SakamotoDepartment of Gastroenterology, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Kazuhiro SakamotoDepartment of Coloproctological Surgery, Juntendo University, Faculty of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND There are 3 methods of treating T1 colorectal cancer (T1 CRC), which include endoscopic resection, endoscopic resection followed by additional colorectal resection, and surgical resection. In this retrospective study, changes in the management of T1 CRC after introduction of endoscopic submucosal dissection (ESD) were investigated by comparison with the 10-year period before introduction of ESD. MATERIAL AND METHODS During a 20-year period from 1996 to 2015, 835 patients with T1 CRC were treated, including 331 patients before introduction of ESD (Group A) and 504 patients after introduction of ESD (Group B). Clinicopathological findings and treatment methods were compared between these 2 groups. RESULTS As the initial treatment, endoscopic treatment was performed in 185 patients (55.9%) in Group A and 288 (57.1%) in Group B. In Group B, ESD was performed in 161 patients (55.9%), accounting for more than half of the T1 CRC patients receiving endoscopic treatment. In Groups A and B, observation after endoscopic resection was selected for 54.2% and 67.3% of T1a patients, respectively (p=0.04). A similar trend was noted for T1b patients, and there was no significant difference of the treatment approach. Among all T1 CRC patients, the percentage undergoing observation after endoscopic resection was significantly higher in Group B than in Group A (34.3% vs. 26.9%, p=0.02), and the percentage of patients undergoing additional colorectal resection was significantly lower in Group B (22.8% vs. 29.0%, p=0.04). CONCLUSIONS After introduction of ESD, it was performed in more than half of all patients with T1 CRC undergoing endoscopic treatment. The percentage of patients undergoing observation following endoscopic resection of T1 CRC increased after introduction of ESD.

Indexed as

AdenocarcinomaAgedAged, 80 and overColonoscopyColorectal NeoplasmsEndoscopic Mucosal ResectionFemaleHumansIntestinal MucosaMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPostoperative ComplicationsRetrospective StudiesTreatment Outcome

Identifiers

PMID30267631
PMCPMC6178867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.